The breadth of systemic activity reflects the peptide's interaction with foundational signaling pathways (NO, VEGF, growth hormone receptor) that operate across nearly all tissue systems
The peptide addresses these limitations by directly activating the cellular machinery responsible for fat breakdown in adipocytes
Some patients have primarily barrier dysfunction, while others have more microbial-driven inflammation
It therefore follows that BPC 157 is a novel cytoprotection mediator, one that is very safe and showed no side effects in clinical trials (i.e., in use for ulcerative colitis), and wherein a lethal dose (LD1) was not achieved in toxicology studies (for review, see [1,9,33,93])
tract when you have leaky gut. We use prebiotic fiber (foods or powders) to feed the good bacteria and (for non-CIRS patients) a little bit of good yeast to re-create a healthy gut microbiome